C-terminal domain of SMYD3 serves as a unique HSP90-regulated motif in oncogenesis

44Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

Abstract

The SMYD3 histone methyl transferase (HMTase) and the nuclear chaperone, HSP90, have been independently implicated as proto-oncogenes in several human malignancies. We show that a degenerate tetratricopeptide repeat (TPR)-like domain encoded in the SMYD3 C-terminal domain (CTD) mediates physical interaction with HSP90. We further demonstrate that the CTD of SMYD3 is essential for its basal HMTase activity and that the TPR-like structure is required for HSP90-enhanced enzyme activity. Loss of SMYD3-HSP90 interaction leads to SMYD3 mislocalization within the nucleus, thereby losing its chromatin association. This results in reduction of SMYD3-mediated cell proliferation and, potentially, impairment of SMYD3's oncogenic activity. These results suggest a novel approach for blocking HSP90-driven malignancy in SMYD3-overexpressing cells with a reduced toxicity profile over current HSP90 inhibitors.

Cite

CITATION STYLE

APA

Brown, M. A., Foreman, K., Harriss, J., Das, C., Zhu, L., Edwards, M., … Tucker, H. (2015). C-terminal domain of SMYD3 serves as a unique HSP90-regulated motif in oncogenesis. Oncotarget, 6(6), 4005–4019. https://doi.org/10.18632/oncotarget.2970

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free